RANDOMIZED EVALUATION OF VAD INTERVENTION BEFORE INOTROPIC THERAPY

Brief Description Of Study

REVIVE-IT is a two-part study consisting of a trial and a registry. The REVIVE-IT Trial is a prospective, randomized, open-label, multicenter trial, evaluating the HeartMate II® LVAS versus a control group consisting of optimal medical management (OMM) in selected non-inotrope dependent, ambulatory, moderately advanced heart failure patients who are not candidates for heart transplantation based upon assessment of comorbidities and age. Patients are randomized to HeartMate II® LVAS or OMM in a 1:1 ratio.

Clinical Study Identifier: 818178

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: RANDOMIZED EVALUATION OF VAD INTERVENTION BEFORE INOTROPIC THERAPY
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.